Formulation: A solid
Formal Name: L-tyrosyl-D-alanyl-L-phenylalanyl-L-α-glutamyl-L-valyl-L-valyl-glycinamide, trifluoroacetate salt
Purity: ≥98%
Formula Markup: C38H54N8O10 • XCF3COOH
Formula Weight: 782,9
Shelf life (days): 1460
Notes: Deltorphin II is a peptide agonist of δ2-opioid receptors.{25533,37715} It is selective for δ-opioid receptors over μ- and κ-opioid receptors in radioligand bindings assays (Kis = 0.0033, >1, and >1 µM, respectively) and induces [35S]GTPγS binding in mouse brain membrane preparations (EC50 = 0.034 µM). Deltorphin II (0.12 mg/kg) decreases the infarction zone:risk zone ratio in a rat model of myocardial ischemia-reperfusion injury induced by coronary occlusion, an effect that can be reversed by the δ2-opioid receptor antagonist naltriben but not the δ1-opioid receptor antagonist BNTX.{62411} Intrathecal administration of deltorphin II (15 µg/animal) increases latency to withdraw in the paw pressure and tail-flick tests in rats.{46878}